Further studies to elucidate the mechanism by which RIPsC prevents CD8+ T cell infiltration and to determine CD4+ and CD8+ T lymphocyte subtypes will contribute to the understanding of the course of ACD. The gene discussed is CD8A; the disease is granular corneal dystrophy type II.